The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Survival outcomes for patients with high-grade serous ovarian carcinoma may be ...

Neoadjuvant chemotherapy with interval debulking surgery is associated with higher complete gross resection rates and lower postoperative mortality in advanced epithelial ovarian cancer. The use of ...

Significant disparities exist in the adoption of minimally invasive interval debulking surgery for advanced ovarian cancer, with gaps potentially widening as the procedure becomes more common.

December 23, 2008 — In the treatment of advanced ovarian cancer, neoadjuvant chemotherapy before surgical debulking may be the new standard of care — especially in countries where the scheduling of a ...

Please provide your email address to receive an email when new articles are posted on . The tool helped identify post-discharge complications and may reduce admissions. The data from use of these ...

Improved overall survival for patients with advanced ovarian, tubal, and primary peritoneal carcinoma as a result of a change in surgical approach: A follow-up study No significant financial ...

CHICAGO -- Upfront surgery for advanced ovarian cancer failed to improve overall survival (OS) versus interval debulking but did improve progression-free survival (PFS) for the first time in a phase ...

Patients with advanced ovarian cancer who achieved complete cytoreduction had the best outcomes, regardless of the number of chemotherapy cycles before surgery. Increasing the number of chemotherapy ...

For patients with high-grade serous ovarian cancer, an aggressive form of the disease, surgery to remove the tumor before starting chemotherapy should lead to better outcomes than the reverse, ...

Study findings from this surgical case series may be useful in counseling men with high-risk prostate cancer features before choosing initial local treatment. Surgery remains a viable option as part ...